Oncology Biosimilars Market
According to Intent Market Research, the Oncology Biosimilars Market is expected to grow from USD 7.6 Billion in 2024-e at a CAGR of 14.5% to touch USD 17.2 Billion by 2030. The Oncology Biosimilars Market is dominated by key players such as Pfizer Inc., Novartis AG (Sandoz), Biocon Limited, Mylan N... Read More